Click to Enlarge
Europe’s deepening vaccine “woes” make the Financial Times’s splash, after Brussels warned that supplies from pharmaceutical firm AstraZeneca would fall short in the first quarter. The paper says it comes on top of several EU countries suspending use of the jab over bloodclot fears and what the paper says are fading hopes that the US will provide extra doses.